Natural products as tools for discovering new cancer targets

Natural Products and Cancer Drug Discovery

Volumn , Issue , 2013, Pages 213-237

  Beutler, John A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84891130399     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-4654-5_9     Document Type: Chapter

References (123)

1. Abida WM, Carter BT, Althoff EA et al (2002) Receptor-dependence of the transcription read-out in a small-molecule three-hybrid system. Chembiochem 3:887-895.
2. Acton EM, Narayanan VL, Risbood PA et al (1994) Anticancer specificity of some ellipticinium salts against human brain tumors in vitro. J Med Chem 37:2185-2189.
3. Alexander MD, Burkart MD, Leonard MS et al (2006) A central strategy for converting natural products into fluorescent probes. Chembiochem 7:409-416.
4. Aoki S, Watanabe Y, Sanagawa M et al (2006) Cortistatins A, B, C, and D, anti-angiogenic steroidal alkaloids, from the marine sponge Corticium simplex. J Am Chem Soc 128:3148-3149.
5. Bai R, Cichacz ZA, Herald CL et al (1993) Spongistatin 1, a highly cytotoxic, sponge-derived, marine natural product that inhibits mitosis, microtubule assembly, and the binding of vinblastine to tubulin. Mol Pharmacol 44:757-766.
6. Baker K, Sengupta D, Salazar-Jimenez G et al (2003) An optimized dexamethasone-methotrexate yeast 3-hybrid system for high-throughput screening of small molecule-protein interactions. Anal Biochem 315:134-137.
7. Bell MR, Johnson JR, Wildi BS et al (1958) The structure of gliotoxin. J Am Chem Soc 80:1001.
8. Beutler JA (2009) Natural products as a foundation for drug discovery. Curr Protoc Pharmacol 46:9.11.1-9.11.21.
9. Beutler JA, Shoemaker RH, Johnson T et al (1998) Cytotoxic geranyl stilbenes from Macaranga schweinfurthii. J Nat Prod 61:1509-1512.
10. Beutler JA, McCall KL, Herbert K et al (2000) Novel cytotoxic diterpenes from Casearia arborea. J Nat Prod 63:657-661.
11. Beutler JA, Kang M-I, Robert F et al (2009) Quassinoid inhibition of AP-1 function does not correlate with cytotoxicity or protein synthesis inhibition. J Nat Prod 72:503-506.
12. Blaskovich MA, Sun J, Cantor A et al (2003) Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice. Cancer Res 63: 1270-1279.
13. Bowman BJ, Bowman EJ (2002) Mutations in subunit c of the vacuolar ATPase confer resistance to bafilomycin and identify a conserved antibiotic binding site. J Biol Chem 277:3965-3972.
14. Bowman EJ, Gustafson KR, Bowman BJ et al (2003) Identification of a new chondropsin class of antitumor compound that selectively inhibits V-ATPases. J Biol Chem 278:44147-44152.
15. Boyd MR, Farina C, Belfiore P et al (2001) Discovery of a novel antitumor benzolactone enamide class that selectively inhibits mammalian vacuolar-type (H+)-ATPases. J Pharmacol Exp Ther 297:114-120.
16. Brandt GE, Schmidt MD, Prisinzano TE et al (2008) Gedunin, a novel hsp90 inhibitor: semisynthesis of derivatives and preliminary structure-activity relationships. J Med Chem 51: 6495-6502.
17. Butler MS (2008) Natural products to drugs: natural product-derived compounds in clinical trials. Nat Prod Rep 25:475-516.
18. Cantrell CL, Gustafson KR, Cecere MR et al (2000) Chondropsins A and B, novel tumor cell growth-inhibitory macrolide lactams from the marine sponge Chondropsis sp. J Am Chem Soc 122:8825-8829.
19. Cee VJ, Chen DY, Lee MR et al (2009) Cortistatin A is a high-affinity ligand of protein kinases ROCK, CDK8, and CDK11. Angew Chem Int Ed Engl 48:8952-8957.
20. Chakraborti SK, De BK, Bandyopadhyay T (1974) Variations in the antitumour constituents of Withania somnifera Dunal. Experientia 30:852-853.
21. Chan J, Khan SN, Harvey I et al (2004) Eukaryotic protein synthesis inhibitors identified by comparison of cytotoxicity profiles. RNA 10:528-543.
22. Chen JK, Taipale J, Cooper MK et al (2002) Inhibition of hedgehog signaling by direct binding of cyclopamine to smoothened. Genes Dev 16:2743-2748.
23. Chowdhury K, Neogy RK (1975) Mode of action of Withaferin A and Withanolide D. Biochem Pharmacol 24:919-920.
24. Cook KM, Hilton ST, Mecinovic J et al (2009) Epidithiodiketopiperazines block the interaction between hypoxia-inducible factor-1alpha (HIF-1alpha) and p300 by a zinc ejection mechanism. J Biol Chem 284:26831-26838.
25. Cuendet M, Christov K, Lantvit DD et al (2004) Multiple myeloma regression mediated by bruceantin. Clin Cancer Res 10:1170-1179.
26. Czakó B, Kürti L, Mammoto A et al (2009) Discovery of potent and practical antiangiogenic agents inspired by cortistatin A. J Am Chem Soc 131:9014-9019.
27. Decosterd LA, Gustafson KR, Cardellina JH II et al (1994) The differential cytotoxicity of cardenolides from Thevetia ahouia. Phytother Res 8:74-77.
28. Derbre S, Gil S, Taverna M et al (2008) Highly cytotoxic and neurotoxic acetogenins of the Annonaceae: new putative biological targets of squamocin detected by activity-based protein profiling. Bioorg Med Chem Lett 18:5741-5744.
29. Dixon N, Wong LS, Geerlings TH et al (2007) Cellular targets of natural products. Nat Prod Rep 24:1288-1310.
30. Erickson KL, Beutler JA, Cardellina JH II et al (1997) Salicylihalamides A and B, novel cytotoxic macrolides from the marine sponge Haliclona sp. J Org Chem 62:8188-8192.
31. Ernst-Russell MA, Chai CLL, Hurne AM et al (1999) Structure revision and cytotoxic activity of the scabrosin esters, epidithiopiperazinediones from the lichen Xanthoparmelia scabrosa. Aust J Chem 52:279-283.
32. Falsey RR, Marron MT, Gunaherath GMKB et al (2006) Actin filament aggregation induced by withferin A is mediated by annexin II. Nat Chem Biol 2:33-38.
33. Fischer JD, Liao L, Carvalho PC et al (2010) Dynamic proteomic overview of glioblastoma cells (A172) exposed to perillyl alcohol. J Proteomics 73(5):1018-1027.
34. Frye SV (2010) The art of the chemical probe. Nat Chem Biol 6:159-161.
35. Fukamiya N, Lee KH, Muhammad I et al (2005) Structure-activity relationships of quassinoids for eukaryotic protein synthesis. Cancer Lett 220:37-48.
36. Fuller RW, Cardellina JH II, Cragg GM et al (1994) Cucurbitacins; differential cytotoxicity, dereplication and first isolation from Gonystylus keithii. J Nat Prod 57:1442-1445.
37. Funabashi Y, Horiguchi T, Iinuma S et al (1994) TAN-1496 A, C and E, diketopiperazine antibiotics with inhibitory activity against mammalian DNA topoisomerase I. J Antibiot 47: 1202-1218.
38. Gitter S, Gallily R, Shohat B et al (1961) Studies on the antitumor effect of cucurbitacins. Cancer Res 21:516-521.
39. Goswami SK, Das DK (2009) Resveratrol and chemoprevention. Cancer Lett 284:1-6.
40. Guo C, LaCour TG, Fuchs PL (1999) On the relationship of OSW-1 to the cephalostatins. BioMed Chem Lett 9:419-424.
41. Gupta RS, Chopra A, Stetsko DK (1986) Cellular basis for the species differences in sensitivity to cardiac glycosides (digitalis). J Cell Physiol 127:197-206.
42. Hegde VR, Dai P, Patel M et al (1997) Novel thiodiketopiperazine fungal metabolites as epidermal growth factor receptor antagonists. Tetrahedron Lett 38:911-914.
43. Henrich CJ, Goncharova EI, Wilson JA et al (2007) Natural products active in aberrant c-Kit signaling. Chem Biol Drug Des 69:321-330.
44. Hieronymus H, Lamb J, Ross KN et al (2006) Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators. Cancer Cell 10:321-330.
45. Hovhannisyan A, Matz M, Gebhardt R (2009) From teratogens to potential therapeutics: natural inhibitors of the Hedgehog signaling network come of age. Planta Med 75:1371-1380.
46. Hsiang YH, Hertzberg R, Hecht S et al (1985) Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J Biol Chem 260:14873-14878.
47. Hurne AM, Chai CL, Moerman K et al (2002) Influx of calcium through a redox-sensitive plasma membrane channel in thymocytes causes early necrotic cell death induced by the epipolythiodioxopiperazine toxins. J Biol Chem 277:31631-31638.
48. Incardona JP, Gaffield W, Kapur RP et al (1998) The teratogenic Veratrum alkaloid cyclopamine inhibits sonic hedgehog signal transduction. Development 125:3553-3562.
49. Jang M, Cai L, Udeani GO et al (1997) Cancer chemopreventative activity of resveratrol, a natural product derived from grapes. Science 275:218-220.
50. Jolad SD, Hoffman JJ, Cole JR et al (1981) 3J-O-Methylevomonoside: a new cytotoxic cardiac glycoside from Thevetia ahouia A.DC (Apocynaceae). J Org Chem 46:1946-1947.
51. Keeler RF, Binns W (1968) Teratogenic compounds of Veratrum californicum (Durand). V. Comparison of cyclopean effects of steroidal alkaloids from the plant and structurally related compounds from other sources. Teratology 1:5-10.
52. Kerrigan JE, Pilch DS (2001) A structural model for the ternary cleavable complex formed between human topoisomerase I, DNA, and camptothecin. Biochemistry 40:9792-9798.
53. Keskin O, Bahar I, Jernigan RL et al (2000) Characterization of anticancer agents by their growthinhibitory activity and relationships to mechanism of action and structure. Anticancer Drug Design 15:79-98.
54. Kigoshi H, Suenaga K, Mutou T et al (1996) Aplyronine A, a potent antitumor substance of marine origin, aplyronines B and C and artificial analogues: total synthesis and structure-cytotoxicity relationships. J Org Chem 61:5326-5351.
55. Kotake Y, Sagane K, Owa T et al (2007) Splicing factor SF3b as a target of the antitumor natural product pladienolide. Nat Chem Biol 3:570-575.
56. Kuder CH, Neighbors JD, Hohl RJ et al (2009) Synthesis and biological activity of a fluorescent schweinfurthin analogue. Bioorg Med Chem 17:4718-4723.
57. Kung AL, Zabludoff SD, France DS et al (2004) Small molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathway. Cancer Cell 6:33-43.
58. Kupchan SM, Britton RW, Ziegler MF et al (1973) Bruceantin, a new potent antileukemic simaroubolide from Brucea antidysenterica. J Org Chem 38:178-179.
59. Kuroda T, Suenaga K, Sakakura A et al (2006) Study of the interaction between actin and antitumor substance aplyronine A with a novel fluorescent photoaffinity probe. Bioconjug Chem 17:524-529.
60. Lamb J (2007) The Connectivity Map: a new tool for biomedical research. Nat Rev Cancer 7:54-60.
61. Lamb J (2010) Connectivity Map 02. http://www.broadinstitute.org/cmap/. Accessed 23 Feb 2010.
62. Lamb J, Crawford ED, Peck D et al (2006) The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313:1929-1935.
63. Lavie D, Glotter E, Shvo Y (1965) Constituents of Withania somnifera Dun. Part IV. The structure of withaferin A. J Chem Soc 50:7517-7531.
64. Li JW, Vederas JC (2009) Drug discovery and natural products: end of an era or an endless frontier? Science 325:161-165.
65. Maheshwari RK, Singh AK, Gaddipati J et al (2006) Multiple biological activities of curcumin: a short review. Life Sci 78:2081-2087.
66. McCormick JL, McKee TC, Cardellina JH II et al (1996) Cytotoxic triterpenes from a marine sponge, Stelletta sp. J Nat Prod 59:1047-1050.
67. McInnes AG, Taylor A, Walter JA (1976) The structure of chetomin. J Am Chem Soc 98:6741.
68. McKee TC, Galinis DL, Pannell LK et al (1998) The lobatamides, novel cytotoxic macrolides from southwestern Pacific tunicates. J Org Chem 63:7805-7810.
69. Mijatovic T, Van QE, Delest B et al (2007) Cardiotonic steroids on the road to anti-cancer therapy. Biochim Biophys Acta 1776:32-57.
70. Mimaki Y, Kuroda M, Kameyama A et al (1997) Cholestane glycosides with potent cytostatic activities on various tumor cells from Ornithogalum saundersiae bulbs. BioMed Chem Lett 7:633-636.
71. Mizui Y, Sakai T, Iwata M et al (2004) Pladienolides, new substances from culture of Streptomyces platensis Mer-11107. III. In vitro and in vivo antitumor activities. J Antibiot 57:188-196.
72. Moerman KL, Chai CL, Waring P (2003) Evidence that the lichen-derived scabrosin esters target mitochondrial ATP synthase in P388D1 cells. Toxicol Appl Pharmacol 190:232-240.
73. Monks A, Scudiero DA, Johnson GS et al (1997) The NCI anti-cancer drug screen: a smart screen to identify effectors of novel targets. Anticancer Drug Des 12:533-541.
74. Morre DJ, Grieco PA, Morre DM (1998) Mode of action of the anticancer quassinoids-inhibition of the plasma membrane NADH oxidase. Life Sci 63:595-604.
75. Newman DJ, Cragg GM (2006) Natural products from invertebrates and microbes as modulators of antitumor targets. Curr Drug Targets 7:279-304.
76. Newman DJ, Cragg GM (2007) Natural products as sources of new drugs over the last 25 years. J Nat Prod 70:461-477.
77. Ojima I, Duclose O, Dormán G et al (1995) A new paclitaxel photoaffinity analog with a 3-(4-benzoylphenyl)propanoyl probe for characterization of drug-binding sites on tubulin and p-glycoprotein. J Med Chem 38:3891-3894.
78. Onodera H, Hasegawa A, Tsumagari N et al (2004) MPC1001 and its analogues: new antitumor agents from the fungus Cladorrhinum species. Org Lett 6:4101-4104.
79. Parsons AB, Lopez A, Givoni IE et al (2006) Exploring the mode-of-action of bioactive compounds by chemical-genetic profiling in yeast. Cell 126:611-625.
80. Paull KD, Shoemaker RH, Hodes L et al (1989) Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm. J Natl Cancer Inst 81:1088-1092.
81. Paull KD, Lin CM, Malspeis L et al (1992) Identification of novel antimitotic agents acting at the tubulin level by computer-assisted evaluation of differential cytotoxicity data. Cancer Res 52:3892-3900.
82. Perkins S, Verschoyle RD, Hill K et al (2002) Chemopreventive efficacy and pharmacokinetics of curcumin in the min/+ mouse, a model of familial adenomatous polyposis. Cancer Epidemiol Biomarkers Prev 11:535-540.
83. Pettit GR, Inoue M, Kamano Y et al (1988) Isolation and structure of the powerful cell growth inhibitor cephalostatin 1. J Am Chem Soc 110:2006-2007.
84. Pettit GR, Cichacz ZA, Gao F et al (1993a) Isolation and structure of the remarkable human cancer cell growth inhibitors spongistatins and 3 from an eastern Indian Ocean Spongia sp. J Chem Soc Chem Commun 14:1166-1168.
85. Pettit GR, Cichacz ZA, Gao F et al (1993b) Isolation and structure of spongistatin 1. J Org Chem 58:1302-1304.
86. Qi H, Wei L, Han Y et al (2010) Proteomic characterization of the cellular response to chemopreventive triterpenoid astragaloside IV in human hepatocellular carcinoma cell line HepG2. Int J Oncol 36:725-735.
87. Redinbo MR, Stewart L, Kuhn P et al (1998) Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA. Science 279:1504-1513.
88. Rosati A, Quaranta E, Ammirante M et al (2004) Quassinoids can induce mitochondrial membrane depolarisation and caspase 3 activation in human cells. Cell Death Differ 11:S216-S218.
89. Saito S, Watabe S, Ozaki H et al (1996) Novel actin depolymerizing macrolide aplyronine A. J Biochem 120:552-555.
90. Sakamoto S, Kabe Y, Hatakeyama M et al (2009) Development and application of high-performance affinity beads: toward chemical biology and drug discovery. Chem Rec 9:66-85.
91. Schyschka L, Rudy A, Jeremias I et al (2008) Spongistatin 1: a new chemosensitizing marine compound that degrades XIAP. Leukemia 22:1737-1745.
92. Shi LM, Myers TG, Fan Y et al (1998) Mining the National Cancer Institute anticancer drug discovery database: cluster analysis of ellipticine analogs with p53-Inverse and central nervous system-selective patterns of activity. Mol Pharmacol 53:241-251.
93. Shoemaker RH (2006) The NCI60 human tumour cell line anticancer drug screen. Nat Rev Cancer 6:813-823.
94. Sleno L, Emili A (2008) Proteomic methods for drug target discovery. Curr Opin Chem Biol 12:46-54.
95. Suenaga K, Kamei N, Okugawa Y et al (1997) Cytotoxicity and actin depolymerizing activity of aplyronine A, a potent antitumor macrolide of marine origin, and the natural and artificial analogs. BioMed Chem Lett 7:269-274.
96. Sugie Y, Hirai H, Inagaki T et al (2001) A new antibiotic CJ-17,665 from Aspergillus ochraceus. J Antibiot 54:911-916.
97. Sun J, Blaskovich MA, Jove R et al (2005) Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity. Oncogene 24:3236-3245.
98. Sun B, Wu S, Li L et al (2009) A metabolomic analysis of the toxicity of Aconitum sp. alkaloids in rats using gas chromatography/mass spectrometry. Rapid Commun Mass Spectrom 23: 1221-1228.
99. Taipale J, Chen JK, Cooper MK et al (2000) Effects of oncogenic mutations in smoothened and patched can be reversed by cyclopamine. Nature 406:1005-1009.
100. Torigoe T, Izumi H, Ise T et al (2002) Vacuolar H(+)-ATPase: functional mechanisms and potential as a target for cancer chemotherapy. Anticancer Drugs 13:237-243.
101. Torrance CJ, Agrawal V, Vogelstein B et al (2001) Use of isogenic human cancer cells for highthroughput screening and drug discovery. Nat Biotechnol 19:940-945.
102. Turbyville TJ, Gürsel DB, Tuskan RG et al (2010) Schweinfurthin A selectively inhibits proliferation and Rho signaling in glioma and neurofibromatosis type 1 tumor cells in an NF1-GRD dependent manner. Mol Cancer Ther 9(5):1234-1243.
103. Ulrich NC, Kodet JG, Mente NR et al (2010) Structural analogues of schweinfurthin F: probing the steric, electronic and hydrophobic properties of the D-ring substructure. Bioorg Med Chem 18:1676-1683.
104. Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324:1029-1033.
105. Vidalin O, Muslmani M, Estienne C et al (2009) In vivo target validation using gene invalidation, RNA interference and protein functional knockout models: it is the time to combine. Curr Opin Pharmacol 9:669-676.
106. Vistica DT, Kenney S, Hursey ML et al (1994) Cellular uptake as a determinant of cytotoxicity of quaternized ellipticines to human brain tumor cells. Biochem Biophys Res Commun 200: 1762-1768.
107. Vistica DT, Kenney S, Hursey ML et al (1996) Role of membrane potential in the accumulation of quaternized ellipticines by human tumor cell lines. J Pharmacol Exp Ther 279:1018-1025.
108. Vockley J, Ozenberger B (2012) The Cancer Genome Atlas. http://cancergenome.nih.gov/. Accessed 29 Aug 2012.
109. Waksman SA, Bugie E (1944) Chaetomin, a new antibiotic substance produced by chaetomium cochliodes: I. Formation and properties. J Bacteriol 48:527-530.
110. Weinstein JN, Kohn KW, Grever MR et al (1992) Neural computing in cancer drug development: predicting mechanism of action. Science 258:447-451.
111. Weinstein JN, Myers TG, O'Connor PM et al (1997) An information-intensive approach to the molecular pharmacology of cancer. Science 275:343-349.
112. Williams DE, Bombuwala K, Lobkovsky E et al (1998) Ambewelamides A and B, antineoplastic epidithiapiperazinediones isolated from the lichen Usnea sp. Tetrahedron Lett 39:9579-9582.
113. Wiseman CL, Yap HY, Bedikian AY et al (1982) Phase II trial of bruceantin in metastatic breast carcinoma. Am J Clin Oncol 5:389-391.
114. Wosikowski K, Schuurhuis D, Johnson K et al (1997) Identification of epidermal growth factor receptor and c-erbB2 pathway inhibitors by correlation with gene expression patterns. J Natl Cancer Inst 89:1505-1515.
115. Wrona IE, Lowe JT, Turbyville TJ et al (2009) Synthesis of a 35-member stereoisomer library of bistramide A: evaluation of effects on actin state, cell cycle and tumor cell growth. J Org Chem 74:1897-1916.
116. Wu L, Smythe AM, Stinson SF et al (1992) Multidrug-resistant phenotype of disease-oriented panels of human tumor cell lines used for anticancer drug screening. Cancer Res 52: 3029-3034.
117. Wulff JE, Siegrist R, Myers AG (2007) The natural product avrainvillamide binds to the oncoprotein nucleophosmin. J Am Chem Soc 129:14444-14451.
118. Xu GW, Mawji IA, Macrae CJ et al (2008) A high-content chemical screen identifies ellipticine as a modulator of p53 nuclear localization. Apoptosis 13:413-422.
119. Yamada K, Ojika M, Ishigaki T et al (1993) Aplyronine A, a potent antitumor substance, and the congeners aplyronines B and C isolated from the sea hare Aplysia kurodai. J Am Chem Soc 115:11020-11021.
120. Yang H, Shi G, Dou QP (2007) The tumor proteasome is a primary target for the natural anticancer compound Withaferin A isolated from "Indian winter cherry". Mol Pharmacol 71:426-437.
121. Yoder B, Norris A, Miller JS et al (2006) Cytotoxic prenylated stilbenes and flavonoids from Macaranga alnifolia from the Madagascar rain forest. J Nat Prod 70:342-346.
122. Yu Y, Hamza A, Zhang T et al (2010) Withaferin A targets heat shock protein 90 in pancreatic cancer cells. Biochem Pharmacol 79:542-551.
123. Yue P, Turkson J (2009) Targeting STAT3 in cancer: how successful are we? Expert Opin Investig Drugs 18:45-56.